Skip to main content
SpringerLink
Log in

Bevacizumab/cisplatin/cyclophosphamide

Asthenia and anaemia: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lorgis V, et al. Metronomic cyclophosphamide with cisplatin and bevacizumab: A new chemotherapeutic regimen for refractory anaplastic ependymoma. Anticancer Research 32: 5067-5070, No. 11, Nov 2012 - France

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/cisplatin/cyclophosphamide. Reactions Weekly 1488, 10 (2014). https://doi.org/10.1007/s40278-014-8772-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8772-9

Search

Navigation